Estimaciones de analistas de Wall Street para Kimberly-Clark Corporation (KMB): precio objetivo de consenso, recomendaciones de compra/mantener/venta y previsiones de ingresos, BPA y EBITDA para los próximos ejercicios.
Sorpresas de Resultados Recientes
| Fecha | BPA Real | BPA Estimado | vs Est. |
|---|---|---|---|
| 2026-10-29 | $1.64 | ||
| 2026-08-04 | $1.80 | $2.01 | -10.4% |
| 2026-04-28 | $1.97 | $1.93 | +2.1% |
| 2026-01-27 | $1.86 | $1.81 | +2.8% |
| 2025-10-30 | $1.82 | $1.75 | +4.0% |
| 2025-08-01 | $1.92 | $1.67 | +15.0% |
| 2025-04-22 | $1.93 | $1.89 | +2.1% |
| 2025-01-28 | $1.50 | $1.51 | -0.7% |
Ratios de valoración
| Ratio P/E | 16.40 |
| Precio / Valor contable | 18.32 |
| EV / EBITDA | 12.60 |
| Rentabilidad por dividendo | 5.29% |
Cuenta de Resultados (10 años)
| Año | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|
| Ingresos | $18.20B | $18.26B | $18.49B | $18.45B | $19.14B | $19.44B | $20.18B | $20.43B | $20.06B | $17.22B |
| Coste de Ventas | $11.55B | $11.71B | $12.89B | $12.41B | $12.32B | $13.45B | $13.96B | $13.40B | $12.88B | $11.09B |
| Beneficio Bruto | $6.69B | $6.59B | $5.60B | $6.04B | $6.82B | $5.99B | $6.22B | $7.03B | $7.18B | $6.13B |
| I+D | $328.0M | $309.0M | $317.0M | $284.0M | $276.0M | $269.0M | $292.0M | $312.0M | $338.0M | 0 |
| Generales y Administrativos | $2.97B | $3.23B | $3.37B | $2.87B | $3.25B | $3.02B | $3.29B | $4.06B | $4.31B | $3.61B |
| Gastos Operativos | $3.31B | $3.23B | $3.37B | $3.04B | $3.58B | $3.43B | $3.54B | $4.69B | $3.97B | $3.64B |
| Beneficio Operativo | $3.38B | $3.36B | $2.23B | $2.99B | $3.24B | $2.56B | $2.68B | $2.34B | $3.21B | $2.49B |
| EBITDA | $4.03B | $4.03B | $2.96B | $3.83B | $3.98B | $3.25B | $3.38B | $3.07B | $3.98B | $3.11B |
| Gastos por Intereses | $319.0M | $318.0M | $263.0M | $261.0M | $252.0M | $256.0M | $282.0M | $293.0M | $270.0M | $256.0M |
| Beneficio Antes de Impuestos | $3.01B | $2.99B | $1.81B | $2.65B | $2.93B | $2.32B | $2.46B | $2.22B | $3.14B | $2.23B |
| Impuestos | $922.0M | $776.0M | $471.0M | $576.0M | $676.0M | $479.0M | $495.0M | $453.0M | $565.0M | $527.0M |
| Beneficio Neto | $2.17B | $2.28B | $1.41B | $2.16B | $2.35B | $1.81B | $1.93B | $1.76B | $2.54B | $2.02B |
| BPA | $6.03 | $6.44 | $4.05 | $6.28 | $6.90 | $5.38 | $5.73 | $5.21 | $7.58 | $6.08 |
| BPA Diluido | $5.99 | $6.40 | $4.03 | $6.24 | $6.87 | $5.35 | $5.72 | $5.21 | $7.55 | $6.07 |
| Acciones en Circulación (Diluidas) | $361.7M | $355.9M | $349.6M | $345.6M | $342.5M | $338.8M | $338.3M | $338.8M | $337.0M | $333.1M |
Precio
| Precio | $98.10 |
| Capitalización | $32.6B |
| Bolsa | NASDAQ |
| País | US |
Empresas relacionadas: ABEV · ADM · CHD · EL · HSY · JBS · K
Explorar sector: Consumer Defensive · Household & Personal Products
Más secciones de KMB: Resumen · Financieros · Valoración · Estadísticas · Técnico · Propiedad · Noticias · Eventos
Descubre más: Radar — señales de acciones infravaloradas · Academia de Inversión — aprende a analizar acciones